February 16, 2016.
The growing threat of the Zika virus must be addressed using a multi-pronged approach, says consulting firm GlobalData.
The firm's analayst for infectious diseases, Mirco Junker, Ph.D., commented: “The first step in fighting the Zika virus is to address the vector responsible for its transferral to humans – mosquitoes. Achievable actions, such as eliminating shallow standing water, using insecticides, and implementing next-generation genetic or microbiological approaches, would all contribute to the reduction of Zika vector populations."
The development of a reliable and cost-effective method to detect Zika infections is also of "paramount importance", said Junker. But while a vaccine offering strong and durable protection against Zika would be an effective long-term solution, the analyst warned that "this could take years to become a reality" as "the current lack of scientific data on [the virus] presents a major barrier".
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.